Dr. Sarah Larson is interested in identifying novel signal pathways and therapeutics for B cell lymphomas and multiple myeloma. She works with the lymphoma and multiple myeloma cell line panels in the Translational Oncology Research Laboratory (TORL) and conducts clinical trials as a member of the Hematologic Malignancies Program and the Lymphoma Program.
Get the latest thought leadership on Myeloma delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for Myeloma Newsletter" for Myeloma news, life with Myeloma stories, Myeloma clinical trials, Myeloma 101 articles and events with Myeloma experts.
Thanks to our HealthTree Community for Myeloma Sponsors:
Follow Us
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / Myeloma Crowd is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811
